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Renal Artery Embolization Using a New
Liquid Embolic Material Obtained by
Partial Hydrolysis of Polyvinyl Acetate
(Embol): Initial Experience in Six Patients
Objective: To evaluate the therapeutic efficacy of a new liquid embolic materi-
al, Embol, in embolization of the renal artery.
Materials and Methods: Embol is a new embolic material obtained by partial
hydrolysis of polyvinyl acetate mixed in absolute ethanol and Iopromide 370 and
manufactured by Schering Korea, Kyonggido, Korea. Six patients who underwent
embolization of the renal artery using Embol were evaluated. Four were male and
two were female and their ages ranged from 11 to 70 (mean, 53) years. Clinical
and radiologic diagnoses referred for renal artery embolization were renal cell
carcinoma (n = 3), renal angiomyolipoma (n = 2) and pseudoaneurysm of the
renal artery (n = 1). After selective renal angiography, Embol was injected
through various catheters, either with or without a balloon occlusion catheter.
Changes in symptoms and blood chemistry which may have been related to renal
artery embolization with Embol were analyzed.
Results: The six patients showed immediate total occlusion of their renal vas-
cular lesions. One of the three in whom renal cell carcinoma was embolized with
Embol underwent radical nephrectomy, and the specimen thus obtained revealed
40% tumor necrosis. In the two patients with angiomyolipomas, the tumors
decreased in size and abdominal pain subsided. Bleeding from pseudoaneurysm
of the renal artery was successfully controlled. Four patients showed symptoms
of post-embolization syndrome, and one of these also showed increased levels of
blood urea nitrogen and creatinine. One patient experienced transient hyperten-
sion.
Conclusion: Embol is easy to use, its radiopacity is adequate and it is a safe
and effective embolic material which provides immediate and total occlusion of
renal vascular lesions.
ince the first introduction of percutaneous transcatheter renal artery em-
bolization in 1964 (1), the devices used in interventional radiology have
made rapid progress and super-selective catheterization is now possible.
For successful renal artery embolization, both the selection of appropriate embolic ma-
terial and adequate operator experience are prerequisites. The embolic materials used
in renal vascular lesions include absolute ethanol, ethibloc, gelfoam, polyvinyl alcohol,
coils and detachable balloons (2). Some of these are, however, hard to prepare and/or
difficult to use in super-selective embolization and may result in incomplete occlusion
and/or recanalization. Embol (Department of Biomedical Engineering, Seoul Health
College, Kyonggido, Korea) is a new embolic material obtained by partial hydrolysis
of polyvinyl acetate mixed in absolute ethanol and Iopromide 370, and manufactured
by Schering Korea, Kyonggido, Korea. Portal vein embolization using Embol has been
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reported (3, 4). We describe the results of six cases of en-
dovascular treatment for renal vascular lesions using this
new liquid embolic material.
MATERIALS AND METHODS
Embol is prepared in a polymerized state and is insoluble
in water. When it comes into contact with blood, ethanol is
washed out, resulting in precipitation of the embolic mater-
ial and obstruction of the vessel. Partial hydrolysis of
polyvinyl acetate increases the hydrophilic property of the
polymer, making it soluble in a larger amount of angio-
graphic contrast medium and increasing the radiopacity of
the solution. We retrospectively reviewed the angiographic
findings and medical records of six patients with renal vas-
cular lesion who had undergone endovascular treatment
with Embol. Four were male and two were female, and
their ages ranged from 11 to 70 (mean, 53) years. Clinical
or radiological diagnoses referred for endovascular treat-
ment were renal cell carcinoma in three patients, angiomy-
olipoma in two and pseudoaneurysm of the renal artery
with retroperitoneal hematoma which developed after re-
nal biopsy in one. Analysis of adverse reactions resulting
from renal artery embolization with Embol continued until
the date of discharge.
Procedures
For angiographic evaluation, percutaneous transfemoral
catheterization using Seldinger s method was employed.
Diagnostic aortography and selective renal angiography in-
volved the use of a 5-Fr Cobra catheter (Cook, Blooming-
ton, Ind.) and the digital subtraction technique. When the
proximal main renal artery was embolized, an iliac sheath
and balloon occlusion catheter were used to exclude possi-
ble regurgitation. In these cases, Embol was injected
through the catheter. Where embolization was performed
superselectively at the segmental artery, various coaxial
catheters were used, without a balloon occlusion catheter.
In one patient with pseudoaneurysm of the renal artery,
stenosis of the proximal renal artery was combined and
Embol was injected percutaneously under sonographic
guidance.
After embolization, the catheter was flushed with 35%
ethanol, and 15 to 20 minutes were allowed for Embol to
precipitate. Post-embolization angiography was then per-
formed. Patient characteristics and the devices used are
summarized in Table 1.
RESULTS
Angiographic results
In all cases the procedures were performed in a single
step, and embolization was performed immediately after
selective renal angiography. During embolization, Embol
was clearly visualized fluoroscopically. Total occlusion of
renal vascular lesions was achieved immediately in all six
patients, although in one, a stainless steel coil (Cook,
Bloomington, Ind.) was also used (Fig. 1). No renal
parenchymal infarction was seen in non-embolized kidney
segments.
Clinical results
One of the three patients with renal cell carcinoma (pa-
tient 1) underwent radical nephrectomy three days after
embolization, and a pathologic specimen revealed 40% tu-
mor necrosis. Nine months after surgery, this patient was
doing well, without tumor recurrence (Fig. 1). One patient
with renal cell carcinoma (patient 2) refused further treat-
ment and was discharged, but was still alive six months af-
ter embolization. The one remaining patient with ad-
vanced renal cell carcinoma (T4) at the time of diagnosis
(patient 3) expired three months after embolization due to
deterioration in his general condition. In both patients with
angiomyolipoma, right lower quadrant abdominal pain was
successfully controlled. Follow-up sonography revealed
that the angiomyolipomas had decreased in size from 7.5
to 6 cm in one patient (Fig. 2) and from 3.1 to 2.3 cm in
the other. In the patient with pseudoaneurysm of the renal
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Table 1. Patient Characteristics and Intervention Devices Used
Pt.No. Indication Tumor Size Catheters Used Level of Embolization Amount of Embol (mL) Other Embolisate
1 RCC 12.5 cm BOC Proximal 10 mL stainless steel coil
2 RCC 04.5 cm Cobra & SP cath. Posteroinferior seg 05 mL none
3 RCC 13 cm.5 Cobra Proximal 10 mL none
4 AML 07.5 cm Cobra Inferior seg 00.2.5 mL none
5 AML 03 cm.5 Mikaelson & Tracker Posterior seg 01 mL none
6 PA 01 cm.5 Biopsy needle Posteroinferior seg 05 mL none
Note. RCC : renal cell carcinoma, AML : angiomyolipoma, PA : pseudoaneurysm, BOC : balloon occlusion catheter, seg : segmental branch
artery and retroperitoneal hematoma, bleeding stopped
immediately after embolization. Serial follow-up sono-
grams indicated that retroperitoneal hematoma resolved
gradually and no recurrent pseudoaneurysm was found
(Fig. 3).
Elevated blood urea nitrogen and creatinine levels were
seen after embolization in one patient with renal cell carci-
noma (patient 2). This patient refused further treatment,
however, and was discharged. The patient with pseudoa-
neurysm of the renal artery (patient 6) experienced renal
failure before embolization and had elevated levels of
blood urea nitrogen and creatinine, though no changes in
these were observed before or after embolization.
Transient elevated blood pressure was also seen in this pa-
tient, but the pressure decreased to normal within three
days, without medication. Post-embolization syndrome of
fever, nausea, vomiting, flank pain and/or leukocytosis oc-
curred in four of six patients (Table 2). At the end of the
procedure, transtumoral shunting of Embol to the renal
vein occurred in one patient (patient 3) with advanced re-
nal cell carcinoma (T4). Embolization was stopped immedi-
ately and balloon occlusion of the proximal renal artery
was performed. Follow-up chest radiographs revealed no
subjective chest symptoms or consolidation.
DISCUSSION
Since Edling first introduced renal artery embolization in
1964 (1), the applications of renal intervention have rapid-
ly extended. Current indications for transcatheter renal
artery embolization include hemorrhage resulting from
trauma or renal tumor, renal arteriovenous malformation,
end-stage renal disease, severe hypertension refractory to
other methods of treatment, and recurrent infected hy-
dronephrosis in a hemophilic patient (5).
There is little support for routine embolization of renal
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Fig. 1. A 46-year-old female with renal cell carcinoma.
A. CT scan of the kidneys shows a huge heterogeneous mass re-
placing almost the entire right kidney, with thrombosis of the renal
vein and inferior vena cava.
B. After balloon occlusion, 10 mL of Embol was injected into the
proximal right renal artery. Stainless steel coil embolization was al-
so performed.
C. Post-embolization aortogram reveals occlusion of the right renal
artery.
cell carcinoma during the immediate preoperative period
(2, 6, 7). It is, rather, performed for conservative purposes
in cases of solitary kidney, bilateral tumors, inoperable cas-
es and tumor bleeding. Indications for the embolization of
angiomyolipomas are a tumor larger than 4 cm or any tu-
mor with continuous symptoms (8, 9). Renal arteriovenous
fistulas and pseudoaneurysms are common complications
occuring at a rate of 0.2 to 2% after renal biopsy (10), and
for these lesions, transscatheter embolization is an effective
method of treatment (10, 11). In all our cases, Embol was
also effective, providing immediate total occlusion of the
renal vascular lesion.
The development of co-axial catheters has facilitated su-
per-selective embolization, with less trauma to unwanted
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Fig. 2. A 66-year-old male with angiomyolipoma.
A. CT scan shows a huge fatty mass, 7.5 cm in diameter, at the infe-
rior pole of the right kidney.
B. Selective renal angiogram shows a hypervascular mass supplied
from the inferior segmental branch of the right kidney. Using a Cobra
catheter, 2.5 mL of Embol was injected.
C. Near-total occlusion of renal arterial branches supplying the an-
giomyolipoma is seen.
Table 2. Adverse Reactions After Embolization with Embol
Pt. No. Hypertension Fever (duration) Flank pain Nausea/Vomiting Leukocytosis
1 + (4 days) + / + +
2 + (5 days) / +
3 + + / +
4 + (1 day) + / 
5 / 
6 + / 
Note. Patient numbers are the same as in Table 1
segments of renal parenchyma (12). In addition, newer em-
bolic materials are still being developed and tested (3, 4,
13-16). Embolic materials used in renal vascular lesions in-
clude absolute ethanol, ethibloc, gelfoam, polyvinyl alco-
hol, isobutyl-2-cyanoacrylate, coils, detachable balloons
and autologous tissues. Some of these materials, however,
involve tedious preparation, unequal suspension, high fric-
tion, difficulty in injecting through a microcatheter, incom-
plete occlusion and recanalization. Since the beginning of
the 1980s, absolute ethanol or a mixture of absolute
ethanol and oidized oil has been the recommended agent
for embolization of renal vascular lesions (2, 7, 9).
Absolute ethanol is fluoroscopically radiolucent, and unin-
tentional embolization of non-target organs can occur.
Embol, on the other hand, is radiopaque and unintentional
embolization of the non-target organs can be prevented.
Intratumoral arteriovenous shunt occurred in our series, at
the end of the procedure, in a patient with renal cell carci-
noma. Embolization was stopped immediately and balloon
occlusion of the proximal renal artery was performed.
After embolization, no pulmonary complication was noted
either clinically or on chest radiographs.
A demerits noted during embolization with Embol is its
high viscosity, and high pressure is thus required for injec-
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Fig. 3. An 11-year-old male with pseudoaneurysm of the renal artery after renal biopsy.
A. CT scan shows retroperitoneal hematoma with anteriorly displaced left kidney.
B. Selective renal angiogram shows pseudoaneurysm of the inferior segmental branch of the left kidney, about 1 cm in size. Stenosis of
approximately 45% at the proximal side of the inferior segmental branch, with post-stenotic dilatation, is also seen.
C. Under sonographic guidance, the pseudoaneurysm was directly punctured with a 22-gauge biopsy needle. Five mL of Embol was in-
jected.
D. The pseudoaneurysm was occluded.
A B
tion, especially when coaxial microcatheters are used. In
addition, there is a waiting time of 15 to 20 minutes for
Embol to precipitate, and persistent pain occurs during em-
bolization, though this is less than when absolute alcohol is
used. A further disadvantage of Embol is the fact that it is
difficult to ascertain the exact point before termination of
the procedure at which precipitation actually occurs.
The reported complications of renal artery embolization
include renal failure, post-infarction syndrome, gas forma-
tion in necrotic tissue and unintentional embolization of
non-target organs (5, 17). Post-infarction syndrome was
seen in four of six patients in our study, but the symptoms
subsided with conservative care.
In conclusion, Embol is an effective embolic material
which offers immediate and total occlusion of renal vascu-
lar lesions. It also appears to be safe to use, since it is ade-
quately radiopaque during embolization, and no significant
changes in blood pressure, body temperature, or blood
urea nitrogen and creatinine levels occur after emboliza-
tion. To avoid reflux of Embol to non-target organs, bal-
loon occlusion catheters should be used during emboliza-
tion of the proximal main renal artery. When embolization
is performed after super-selection of the segmental branch,
balloon occlusion will not be necessary.
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